SIS
NNVC icon

Sound Income Strategies’s NanoViricides NNVC Stock Holding History

Sound Income Strategies’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300
Closed -$286 – 1731
2026
Q1 		$286 Buy
+300
New +$314 ﹤0.01% 2451

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sound Income Strategies's NNVC Position: Q2 2026 in Review

Sound Income Strategies sold out of NanoViricides (NNVC) in Q2 2026, closing a stake of 300 shares — an estimated $286 sold.

Sound Income Strategies first reported a position in NNVC in Q1 2026 and held it in 1 quarter. The position peaked at $286 in Q1 2026. 47 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Sound Income Strategies reported no remaining NanoViricides position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 300 NanoViricides shares in Q2 2026, an estimated $286.
  • Sound Income Strategies first reported a position in NanoViricides in Q1 2026 and held it in 1 quarter.
  • Sound Income Strategies's NanoViricides position peaked at $286 in Q1 2026.
  • 47 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.